Cargando…
Targeted Dual Intervention-Oriented Drug-Encapsulated (DIODE) Nanoformulations for Improved Treatment of Pancreatic Cancer
Despite recent advancements, effective treatment for pancreatic ductal adenocarcinoma (PDAC) has remained elusive. The overall survival rate in PDAC patients has been dismally low due to resistance to standard therapies. In fact, the failure of monotherapies to provide long-term survival benefits in...
Autores principales: | Madamsetty, Vijay Sagar, Pal, Krishnendu, Dutta, Shamit Kumar, Wang, Enfeng, Mukhopadhyay, Debabrata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281578/ https://www.ncbi.nlm.nih.gov/pubmed/32397114 http://dx.doi.org/10.3390/cancers12051189 |
Ejemplares similares
-
Synchronous inhibition of mTOR and VEGF/NRP1 axis impedes tumor growth and metastasis in renal cancer
por: Pal, Krishnendu, et al.
Publicado: (2019) -
Co-delivery of everolimus and vinorelbine via a tumor-targeted liposomal formulation inhibits tumor growth and metastasis in RCC
por: Pal, Krishnendu, et al.
Publicado: (2019) -
Preclinical efficacy of the novel competitive NAMPT inhibitor STF-118804 in pancreatic cancer
por: Espindola-Netto, Jair Machado, et al.
Publicado: (2017) -
Role of PLEXIND1/TGFβ Signaling Axis in Pancreatic Ductal Adenocarcinoma Progression Correlates with the Mutational Status of KRAS
por: Vivekanandhan, Sneha, et al.
Publicado: (2021) -
VEGF neutralizing antibody increases the therapeutic efficacy of vinorelbine for renal cell carcinoma
por: Sinha, Sutapa, et al.
Publicado: (2010)